Abstract
Priapism is a pathological condition characterized by prolonged erection and is a potential urologic emergency. This chapter outlines the management approach to evaluating, diagnosing, and treating priapism. Key components of the evaluation include expeditious and correct classification of priapism and implementation of appropriate therapies in a timely fashion. If ischemic priapism is the etiology, then stepwise therapeutic maneuvers should be implemented to correct the compartment syndrome, reestablish blood flow, and relieve pain. Medical and surgical management options are reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Burnett AL, Bivalacqua TJ. Priapism: current principles and practice. Urol Clin North Am. 2007;34(4):631–42. viii.
Montague DK, et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170(4 Pt 1):1318–24.
Song PH, Moon KH. Priapism: current updates in clinical management. Korean J Urol. 2013;54(12):816–23.
Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev. 1995;75(1):191–236.
Andersson KE. Pharmacology of penile erection. Pharmacol Rev. 2001;53(3):417–50.
Bivalacqua TJ, et al. New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med. 2012;9(1):79–87.
Bivalacqua TJ, Burnett AL. Priapism: new concepts in the pathophysiology and new treatment strategies. Curr Urol Rep. 2006;7(6):497–502.
Anele UA, Morrison BF, Burnett AL. Molecular pathophysiology of priapism: emerging targets. Curr Drug Targets. 2015;16(5):474–83.
Corbin JD, Francis SH. Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem. 1999;274(20):13729–32.
Broderick GA. Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy. J Sex Med. 2012;9(1):88–103.
Eland IA, et al. Incidence of priapism in the general population. Urology. 2001;57(5):970–2.
Salonia A, et al. European Association of Urology guidelines on priapism. Eur Urol. 2014;65(2):480–9.
Burnett AL, Bivalacqua TJ. Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism? J Sex Med. 2008;5(1):237–40.
Elliott L, et al. Genetic polymorphisms associated with priapism in sickle cell disease. Br J Haematol. 2007;137(3):262–7.
Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol. 1986;135(1):142–7.
Kovac JR, et al. A pathophysiology-based approach to the management of early priapism. Asian J Androl. 2013;15(1):20–6.
Addis G, et al. The physical, social and psychological impact of priapism on adult males with sickle cell disorder. Chronic Illn. 2007;3(2):145–54.
Morrison BF, Burnett AL. Priapism in hematological and coagulative disorders: an update. Nat Rev Urol. 2011;8(4):223–30.
Morrison BF, Burnett AL. Stuttering priapism: insights into pathogenesis and management. Curr Urol Rep. 2012;13(4):268–76.
Emond AM, et al. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. 1980;140(11):1434–7.
Burnett AL, Sharlip ID. Standard operating procedures for priapism. J Sex Med. 2013;10(1):180–94.
Yuan J, et al. Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J Androl. 2008;10(1):88–101.
Melman A, Serels S. Priapism. Int J Impot Res. 2000;12 Suppl 4:S133–9.
Kato GJ. Priapism in sickle-cell disease: a hematologist's perspective. J Sex Med. 2012;9(1):70–8.
LeRoy TJ, Broderick GA. Doppler blood flow analysis of erectile function: who, when, and how. Urol Clin North Am. 2011;38(2):147–54.
Adeyoju AB, et al. Priapism in sickle-cell disease; incidence, risk factors and complications – an international multicentre study. BJU Int. 2002;90(9):898–902.
Muneer A, et al. Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism. J Sex Med. 2008;5(9):2152–9.
Munarriz R, et al. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. J Sex Med. 2006;3(5):918–22.
Bodne DR, et al. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. J Urol. 1987;138(2):310–1.
Lee M, Cannon B, Sharifi R. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. J Urol. 1995;153(4):1182–3.
Burnett AL. Surgical management of ischemic priapism. J Sex Med. 2012;9(1):114–20.
Brant WO, et al. T-Shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol. 2009;181(4):1699–705.
Burnett AL, Pierorazio PM. Corporal “snake” maneuver: corporoglanular shunt surgical modification for ischemic priapism. J Sex Med. 2009;6(4):1171–6.
Winter CC. Cure of idiopathic priapism: new procedure for creating fistula between glans penis and corpora cavernosa. Urology. 1976;8(4):389–91.
Ebbehoj J. A new operation for priapism. Scand J Plast Reconstr Surg. 1974;8(3):241–2.
Segal RL, et al. Corporal Burnett “Snake” surgical maneuver for the treatment of ischemic priapism: long-term followup. J Urol. 2013;189(3):1025–9.
Lue TF, Pescatori ES. Distal cavernosum-glans shunts for ischemic priapism. J Sex Med. 2006;3(4):749–52.
Quackels R. Treatment of a case of priapism by cavernospongious anastomosis. Acta Urol Belg. 1964;32:5–13.
Ralph DJ, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol. 2009;56(6):1033–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Le, B.V., Burnett, A.L. (2016). Management of Priapism. In: Köhler, T., McVary, K. (eds) Contemporary Treatment of Erectile Dysfunction. Contemporary Endocrinology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-31587-4_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-31587-4_24
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-31585-0
Online ISBN: 978-3-319-31587-4
eBook Packages: MedicineMedicine (R0)